iTeos Therapeutics, Inc. (the Company), announced that on June 20, 2023, Joanne Jenkins Lager, M.D., resigned for personal reasons from her position as the Chief Medical Officer effective as of June 23, 2023. Dr. Lager’s decision to resign did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or procedures. In connection with Dr. Lager’s resignation, Dr. Lager and The company expects to enter into a separation agreement that includes a general release of claims .

Under the Agreement, Dr. Lager would be entitled to receive twelve (12) months of salary continuation, and the Company would pay a portion of her COBRA premiums over the same period. Dr. Lager is also expected to serve as a consultant of the Company.